Full Breakdown
China Implements VAT on Contraceptives to Boost Birthrate
12/18/2025, 6:44:15 AM
Introduction of the New Tax Measure
Starting January 1, 2025, China will impose a 13% value-added tax (VAT) on condoms and other contraceptives for the first time in three decades. This decision is part of a broader effort to modernize the country's tax laws and address the declining birthrate. The VAT on contraceptives was included in a law passed in 2024 aimed at updating China's tax regime, which has not taxed these goods since the introduction of nationwide VAT in 1993. Currently, VAT contributes nearly 40% to China's total tax revenue.
Context of China's Birthrate Challenges
In recent years, China has faced a significant decline in its birthrate, which was recorded at 6.77 births per 1,000 people in 2024. This figure, while a slight increase from 2023, remains far below historical levels. The country has been grappling with the consequences of its previous one-child policy, which was in effect for over 30 years. In response, the government has introduced various incentives, such as raising the child limit to three, offering discounts on IVF treatments, and providing cash subsidies for families with additional children. Despite these measures, the birthrate continues to fall, exacerbated by a rising death rate linked to an aging population.
Government's Approach and Public Reaction
The introduction of the VAT on contraceptives has sparked ridicule on social media, with users questioning the effectiveness of such a measure in encouraging childbirth. Critics argue that while the government is attempting to incentivize births, the tax increase on contraceptives may be counterproductive. Some women have reported intrusive inquiries from local government officials regarding their menstrual cycles and childbearing plans, raising concerns about privacy and state intervention in personal matters.
Expert Opinions on the Tax's Impact
Experts have expressed skepticism regarding the effectiveness of the new tax in influencing birth rates. He Yafu, an independent demographer, noted that while it is reasonable to tax contraceptives now that the policy has shifted towards encouraging births, the measure is unlikely to significantly impact fertility rates. Yun Zhou, a sociology professor, emphasized that the tax reflects governmental expectations regarding family behavior, but warned that any difficulties in accessing contraception would disproportionately affect women, particularly those from disadvantaged backgrounds.
Financial Implications and Future Considerations
The financial impact of the VAT on contraceptives is expected to be minimal, with estimates suggesting it could generate an additional 5 billion yuan annually—insignificant compared to China's overall public budget revenue of 22 trillion yuan. Lee Ding, a manager at Dezan Shira & Associates, indicated that revenue generation is likely not the primary motivation behind this tax extension.
Conclusion
As China grapples with its declining birthrate, the introduction of a VAT on contraceptives represents a controversial approach to encourage higher fertility rates. While the government continues to explore various incentives, the effectiveness of such measures remains uncertain, and public sentiment reflects skepticism about the implications of increased state involvement in personal reproductive choices.
